Thursday, May 05, 2016 12:37:11 PM
The near-term target (prior to May 15) would be for a drop to 1.30 -1.35 but longer-term downside targets are well below 1.00. Worst case appears to be 50 cents, which can be justified as the price of a long-term call option on the stock. I ran the numbers using Black-Sholes, with critical assumptions made on volatility, and an expected option life based on cash-reserves and the increased burn-rate. At 50 cents it's a reasonable play on the possibility that they will pull off Herpecide for ocular infections.
I believe Dr. Vivian Boniuk, will be going or has already gone full-time with NNVC. With Dr. Boniuk at the controls, if Herpicide can happen she will make it happen. Then it's a minimum 10 dollar stock.... maybe 20, just based on Herpicide alone.
My biggest fundamental issue is the two classes to stock. I think it's unfair. But I'm a technician not a fundamentalist and I will leave that to the F-Analysts.
Joke: A fundamentalist and a technician go to lunch to find some common ground. During lunch the technician accidentally knocks a steak knife off the table and it goes into the foot of the fundamentalist. He screams in pain and asks why the technician did nothing to help him. The technician's retort - " I don't try to catch falling knives". Technician asks - "What didn't you move your foot?"
Fundamentalist: " I didn't think it would go that low"
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM